Article Details

AstraZeneca Goes With Gracell to Gain an Edge in Next-Generation Cell Therapies

Retrieved on: 2023-12-26 22:27:03

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Goes With Gracell to Gain an Edge in Next-Generation Cell Therapies. View article details on hiswai:

Excerpt

AstraZeneca is paying $1 billion up front to acquire Gracell Biotechnologies, a clinical-stage cell therapy developer. The deal is the latest in a ...

Article found on: medcitynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up